Venture Capital Access Online | The eMarketplace for the Venture Capital Industry



Contact Us





List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory

Buy Now for $119.95 with a free annual update in January 2022

Learn More or Buy Now

VCPro Database 2021 24th Edition -- a downloadable and searchable venture capital database with 6,500+ venture capital and private equity firms worldwide. The most reliable, up-to-date and affordable venture capital directory of its kind. VCPro Database is available in both Windows and macOS versions. It has been published since 1998. (Updated JULY 2021)

Learn More » or Buy Now »

Bio2 Medical® Closes on $3 Million of Venture Debt Financing

GOLDEN, Colo., August 30, 2016-- Bio2 Medical, Inc. is pleased to announce the company officially closed its second tranche of venture debt funding on August 24, 2016. The $3 million provided by Oxford Finance LLC will further enable the company to execute its plan for commercialization of the Angel® Catheter in the United States. The commercialization plan includes hiring a Sales team, building inventory to support the company's projected sales demand, and executing on market development initiatives.

Bio2 Medical's Chairman and Chief Executive Officer, Christopher E. Banas, stated, "This second installment of venture debt, provided by Oxford Finance LLC, strengthens Bio2 Medical's financial position during the launch of the Angel® Catheter, a critical time for strategic investment. This funding will allow us to enhance our Sales infrastructure in the U.S. and make the Angel® Catheter available to a larger group of critically ill patients who would benefit from prophylactic protection from pulmonary embolism. The investment of these funds will drive revenue growth and move us another step closer to profitability. Our stakeholders' continued support of Bio2 Medical and the Angel® Catheter is highlighted by our ongoing ability to raise capital."

The founders and employees of Bio2 Medical have spent more than a decade leading vascular innovation to improve the current standard of care and address important medical problems in the U.S. and overseas markets. With experience and expertise in creating innovative medical technology that addresses critical, unmet clinical needs, Bio2 Medical has introduced its flagship product – the Angel® Catheter – as the first and only IVC filter to receive FDA clearance for a prophylactic use indication. To date, the company has raised $43.1 million of institutional funding and is poised to become a leader in PE prophylaxis and a provider of complementary products, services and solutions.

For more information on Bio2 Medical and the Angel® Catheter, please visit

News Index

Venture Capital Database 



Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm


Venture Capital Database

VCPro Database
Download Trial
Buy Now

Business Plan Tools

Free Business Plan Template


Copyright © 1998-2021 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer